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Abstract
Tumor growth has long been a target of investigation within the context of math-
ematical and computer modelling. The objective of this study is to propose and
analyze a two-dimensional probabilistic cellular automata model to describe avas-
cular solid tumor growth, taking into account both the competition between cancer
cells and normal cells for nutrients and/or space and a time-dependent proliferation
of cancer cells. Gompertzian growth, characteristic of some tumors, is described and
some of the features of the time-spatial pattern of solid tumors, such as compact
morphology with irregular borders, are captured. The parameter space is studied in
order to analyze the occurrence of necrosis and the response to therapy. Our findings
suggest that transitions exist between necrotic and non-necrotic phases (no-therapy
cases), and between the states of cure and non-cure (therapy cases). To analyze
cure, the control and order parameters are, respectively, the highest probability of
cancer cell proliferation and the probability of the therapeutic effect on cancer cells.
With respect to patterns, it is possible to observe the inner necrotic core and the
effect of the therapy destroying the tumor from its outer borders inwards.
Key words: tumor growth, cellular automata, parameter space, necrosis, therapy
1 INTRODUCTION
Neoplastic diseases are the cause of 7 million deaths annually or 12of deaths
worldwide [1]. Mathematical and computer modelling may lead to greater
understanding of the dynamics of cancer progression in the patient [2] [3].
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These techniques may also be useful in selecting better therapeutic strategies
by subjecting available options to computer testing (in silico). Continuous
models have been proposed to describe the stages of tumor growth since the
middle of the 20th century [4]. Initially, a tumor grows exponentially (linear
rate). After this transient stage, the growth rate decreases and a steady state
is attained, due to several factors including a lack of nutrients and hypoxia.
This nonlinear behavior characterizes avascular tumor growth when neovascu-
larization has not yet been triggered. The decelerating avascular growth may
be guided by different rules such as, for example, Gompertzian and logistic
functions. Gompertzian growth has been one of the most studied decelerat-
ing tumor growth over the past 60 years [5], [6] [7]. It is found, for example,
in some solid tumors such as breast carcinomas [8] [9]. It is also observed in
tumors in vitro [10] [11].
Although continuous models are capable of describing the behavior of tumor
growth, it would appear more reasonable to adopt a discrete approach when
describing the prevascular stage. Due to the fact that the angiogenic process
has not triggered early tumor growth, few cancer cells are present and growth
depends predominantly on the interactions of these cells with adjacent cells
and with the environment [12]. In addition, in the discrete approach, it is
easier to capture the time-spatial pattern generated by the model in order to
compare it with actual patterns [13]. Some cellular automata models [14] [15]
and hybrid cellular automata [12] [16] [17] have been proposed to study tumor
growth.
Another important topic that is analyzed in mathematical models is the re-
sponse to therapy, including how tumor growth changes under the effect of
a drug [18]. The focus is directed towards identifying the optimal therapy to
maximize the effect on cancer cells and minimize the effect on normal cells
[19] [20]. Although various continuous chemotherapy models exist [21], [22],
[23], to the best of our knowledge the majority of the discrete models cited in
the literature have not yet been used to investigate this topic.
The objective of this work is to propose a two-dimensional cellular automata
model consisting of 4 states (empty site, normal cell, cancer cell or necrotic
tumor cell) to describe avascular tumor growth. It should be emphasized that
in this study the term tumor growth is used to refer to the number of cancer
cells rather than the volume of the tumor; in other words, it is assumed that
the tumor volume is proportional to the number of cancer cells [4]. Assuming
that the angiogenic process has not yet been triggered, there is no increase
in nutrients, which are uniformly distributed over the lattice. In this simple
model, some relevant processes involved in the prevascular phase of tumor
growth are assessed: a dynamic proliferation of cancer cells and the competi-
tion between normal cells and cancer cells for nutrients and/or space. Since
necrosis is often present in the prevascular stage of tumor growth [10] [24],
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the possibility of necrosis in the model must also be taken into consideration.
Finally, the effect of therapy is included in order to investigate whether the
system evolves to a state of cure.
This paper is organized as follows. In section 2, the model is presented, to-
gether with its local rules, parameters and the scope of the algorithm. Section
3 describes the simulated time series of cell density in the presence or absence
of treatment, and shows the features of the time-spatial pattern of simulated
solid tumors. In section 4, the parameter related to the process of necrosis and
the effect of therapy is analyzed. Finally, in section 5, our results are discussed
from the point of view of the phenomenon and some concluding remarks are
made.
2 THE MODEL
We propose a two-dimensional (L × L) cellular automata model [25] under
periodic boundary conditions, using a Moore neighborhood with a radius of 1.
At the initial condition (t = 0), there is only one cancer cell (to ensure better
visualization, this was taken from the center of the lattice). Since the intention
it to model a non-viral tumor, normal cells would not be transformed into
cancer cells with the exception of the cancer cell that triggers tumor growth
at t = 0 [26]. The lattice represents a tissue sample; there is a cell in each site
that may be in one of four states: normal cell (NoC), cancer cell (CC), necrotic
cell (NeC) or empty site (ES). We assume that the nutrients are uniformly
available over the lattice. In this respect, lack of space is identified with lack
of nutrients in our model.
There is a growth potential Pc value associated with each normal or cancer
cell. Although the two-dimensional character of the model mimics the in vitro
situation, the growth potential of cancer cells simulates the three-dimensional
tumor in vivo in the sense that it represents the total number of cancer cells,
i.e., in addition to the cancer cells on the lattice, the cancer cells generated by
these cells.
The local rules are such that:
(i) The initial value of the mitotic probability of cancer cells is represented
by a parameter p0 that measures the available resources at the beginning
of the tumor. After that, it decreases by a factor ∆pmitot until reaching the
null value:
∆pmitot = exp
−(nnoc(t)
ncc(t)
)2 (1)
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in which nnoc and ncc are the number of normal and cancer cells at time
t, respectively. As shown, ∆pmitot(t) depends only on the dynamics, setting
up a feedback inhibition mechanism [13]: as the tumor grows, ∆pmitot(t)
decreases because of the combined effect of the decrease in the number of
normal cells and the increase in the number of cancer cells. In order to in-
tensify the effect of this mechanism (see [27]), an exponent 2 in equation
(1) is considered. Since there is no new available source of nutrients and/or
space, it decreases as the density of cancer cells increases because the avail-
able nutrients and/or space are reduced. The effect of the proliferation of
cancer cells is that their growth potential increases by a unit at each time
step.
(ii) The cancer cells compete with normal cells for the empty sites, depend-
ing on the potential growth of neighboring cells. According to the majority
rule, a normal cell is displaced by a cancer cell following local battles oc-
curring between healthy and cancerous cells [15].
(iii) If the growth potential of a cancer cell reaches a threshold value that is
a fraction f of the lattice size L, it becomes necrotic and its growth potential
falls to zero.
(iv) Both normal and cancer cells may die, with probabilities pdrugn and
pdrugc, respectively, due to the continuous infusion of a drug that is applied
after tap time steps; in this case, the site becomes empty.
(v) if there are no cancer cells in the neighborhood of a dead cell (empty
site), regeneration of normal cells occurs; if the cancer cells in the neigh-
borhood of a necrotic cell die as a result of the therapy, the necrotic cell is
eliminated.
The algorithm was computationally implemented in FORTRAN 77 in accor-
dance with the following steps: input data; calculate ∆pmitot(t); identify the
state of the cell (choose one of the subroutines: normal cell (NoC), cancer
cell(CC), necrotic cell(NeC), empty site (ES); update the cells of the lattice;
after N iterations, output data.
The input data are the following cellular automata (CA) parameters:
1) The spatial parameters: lattice size L; necrosis threshold fraction f of
lattice size;
2) The temporal parameters: the length of the time series t final and the
initial time of therapy infusion tap;
3) The probabilities of: the initial proliferation of cancer cells p0; the effect
of therapy on normal cells and cancer cells (pdrugn and pdrugc).
The output data are the time series of the density of each type of cell and the
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final configuration of the lattice at any time step. In addition, the time-spatial
configurations, controlled by a package denominated g2 [28] whose commands
are inserted into the computer program in FORTRAN, are generated in ”real
time”. This package may be used in C, PYTHON and PERL.
The following is a description of each subroutine based on the local rules:
a) Normal Cell (NoC) - a random number y is compared to pdrugn. If
y < pdrugn, the growth potential Pnoc is confirmed: if Pnoc = 0, the cell dies
and the site becomes empty; otherwise, it remains occupied by a normal cell
but Pnoc = 0. If y ≥ pdrugn and if there is at least one neighboring cancer
cell, then the normal cell is ’dislocated’, Pnoc = 0 and the site becomes
empty; otherwise it remains a normal cell.
b) Cancer Cell (CC) - if all of its neighbors are cancer cells and its growth
potential reaches a fraction f of lattice size L, the cancer cell becomes
necrotic. Otherwise, a number y is randomly chosen. If y < pdrugc and
t > tap, the potential Pcc is confirmed: if Pcc > 0, it is reduced by a unit and
the cell remains a cancer cell; otherwise the cell dies and the site becomes
empty. Finally, if y ≥ pdrugc, the cell remains a cancer cell; however, its
growth potential Pcc increases by a unit.
c) Necrotic Cell (NeC) - if at least one of its neighbors is neither a
cancer cell nor a necrotic cell, it is eliminated and the site becomes empty;
otherwise, it continues necrotic.
d) Empty Site (ES) - if there are cancer and normal cells in its neigh-
borhood, the local battle between cancer cells and normal cells is such that
if the sum of the potential growth of its neighboring cancer cells is greater
or equal to the sum of the potential growth of its normal cell neighbors,
then the empty site is occupied by a cancer cell that diffuses from one of
the randomly chosen neighbors; otherwise, it is occupied by one of the ran-
domly chosen normal cells that were previously dislocated. If there are only
normal cells in its neighborhood, it becomes a normal cell through a process
of regeneration. Finally, if none of its neighbors are cancer cells or normal
cells, it remains empty.
3 RESULTS: SIMULATED TIME SERIES AND TIME-SPATIAL
PATTERNS
Computational simulations of the model were performed in order to analyze
two classes of behavior: cases in which no treatment was given and treatment
cases. In each subsection, the time series of the simulated tumor as well as
time-spatial patterns are shown.
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Fig. 1. Nonnecrotic tumor: the average of simulated time series of the density
of: a) normal cells, b) cancer cells. We consider Msamples = 200 and the following
parameter values: L = 251, p0 = 0.95, f = 0.6, pdrugn = pdrugc = 0.0.
Fig. 2. Non-necrotic case: assuming Msamples = 200 and the same parameters values
of Figure 1, the average of simulated time series of: a) the number of cancer cells
(grey color); b) the growth potential of cancer cells (black color). The Gompertzian
fitting is applied to (a) (black color) those in which parameters of time series are
α0 = (6.58± 0.09)× 10−2, β = (1.631± 0.008)× 10−2 and n0 = (1.6± 0.06)× 102.
3.1 NO TREATMENT CASE
In the case of no treatment, the following parameters are considered: pdrugn =
pdrugc = tap = 0. For fixed values of L, tfinal and p0, but different values of
f , in Figures 1 and 3, the time series of the density of cells for nonnecrotic
and necrotic tumors, respectively, are shown. In both cases, the cell densities
reach saturated values due to the effects of the competition between normal
cells and cancer cells, and the time-dependent mitotic probability. Comparing
Figures 1b and 3b, the stationary value of cancer cell density is clearly greater
in necrotic tumors than in nonnecrotic ones. This is a consequence of the
fact that ∆pmitot(t) assumes smaller values in necrotic tumors compared to
nonnecrotic ones because it does not depend on the density of necrotic cells.
In both cases, the average of the different samples is considered, corresponding
to different seeds of random numbers.
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Fig. 3. Necrotic case: the average of simulated time series of density of a) normal
cells, b) cancer cells. We consider Msamples = 200 and the following parameter
values: L = 251, p0 = 0.95, f = 0.2, pdrugn = 0.0, pdrugc = 0.0.
Fig. 4. Assuming Msamples = 200 and the same parameters values of Figure
3, the average of simulated time series of: a) the number of cancer cells (grey
color); b) the growth potential of cancer cells (black color). The Gompertzian fit-
ting is applied on (a) (black color) those in which parameters of time series are
α0 = (5.86±0.06)×10−2, β = (1.450±0.006)×10−2 and n0 = (1.926±0.005)×102.
Figures 2a and 4a show that the tumor growth obeys the Gompertzian func-
tion both in nonnecrotic and necrotic cases. This behavior is observed with
respect to the number of cancer cells for a range of values of p0. In Gompertzian
growth, the specific growth rate of the number of cancer cells decreases loga-
rithmically:
1
ncc
dncc
dt
= α0 − β log
(
ncc
n0
)
(2)
where
a) n0 is the initial population of cancer cells;
b) α0 is the specific growth rate of n0 cells at t = 0;
c) β measures how rapidly the curve departs from a singular exponential
and curves over, assuming its characteristic shape.
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The solution of (2) is
ncc(t) = n0 exp
{
α0
β
[1− exp(−βt)]
}
. (3)
It is evident that the stationary value of ncc is ncc∞ = n0 exp(α0/β). Accord-
ing to the Gompertzian fitting represented by equation 3, the results of the
simulations shown in Figures 2 and 4 correspond respectively to the following
parameters:
I) The nonnecrotic tumor: α0 = (6.58± 0.09)× 10−2, β = (1.631± 0.008)×
10−2 and n0 = (1.60± 0.06)× 102
II) The necrotic tumor: α0 = (5.86±0.06)×10−2, β = (1.450±0.006)×10−2
and n0 = (1.926± 0.005)× 102
Comparing the above parameters of (I) and (II), the behavior of nonnecrotic
and necrotic tumors was found to be very similar. It was also found that the
number of cancer cells obeys the Gompertzian fitting.
An important confirmation of our model is shown by comparing the Gom-
pertzian fitting parameters of simulated tumors with the corresponding pa-
rameters of actual tumors [6] [7]. For instance, in the case of the testicular
tumors shown in Table 3 of reference [6], the β values are in the range of
[0.005; 0.016] day−1. Our simulated β values are within the above range if we
consider the time step of our simulations to be one day.
In relation to the parameters α0 and n0, the simulated values are not compa-
rable to the actual values, since no information on the initial size of the tumor
was included in our model. Both α0 and n0 are strongly dependent on that
information.
Finally, it would be very interesting to discover whether it is possible to re-
late the cellular automata no-therapy parameters L, f and p0 with the Gom-
pertzian parameters for the range of values of p0 and to assess whether the
number of cancer cells obeys a Gompertzian growth pattern. In this case, some
preliminary conclusions may be drawn with respect to n∞: it decreases in ac-
cordance with the necrotic parameter f but it increases linearly as a function
of lattice size L and, exponentially with p0. Concerning the other Gompertzian
parameters, the answer to this question is not so simple. Following these con-
clusions leads us to a much more interesting quandary if we want to make
the model more realistic: to estimate realistic ranges of the CA no-therapy
parameters L, f and p0 based on the Gompertzian parameters of actual solid
tumors.
With respect to the time-spatial patterns of the simulated tumors, Figure 5
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Fig. 5. The spatial distribution of states at consequent time steps (see the time
step bar) using the same parameters values of Figure 3 except L = 81 and p0 = 0.8.
The final time step is tfinal = 600. Dark colors (light grey, grey, and dark grey)
correspond, respectively, to normal, cancer, and necrotic cells.
shows the lattice configuration at some time during the steady state in the
necrotic (Figure 5b) cases. Using the g2 package, it was found that, although
tumor growth leads to the compact shape that is characteristic of solid tumors,
the growth process is such that its boundary is irregular for any time t, as, for
example, for the time steps represented in Figure 5. A similar type of behavior
is observed for the time-spatial patterns in the nonnecrotic tumor. In relation
to the process of necrosis, the necrotic region was found to be inside the tumor
at any time t [29] [10], as shown in Figure 5.
3.2 TREATMENT CASE
Figures 6a and 6b show the simulated time series of the number of cancer
cells and normal cells for the different values of pdrugc > p0 and pdrugc < p0
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Fig. 6. a) Successful treatment: the average of simulated time series of the number of
normal cells (-) and cancer cells (circle) assuming Msamples = 200 and the following
parameters values: L = 251, p0 = 0.8, f = 0.2, pdrugc = 0.9, tap = 500, and two
values for pdrugn: 10−4 (dark grey), and 10−2 (light grey); b) Unsuccessful treatment:
the time series of the number of normal cells (-) and cancer cells (circle) assuming
Msamples = 200 and the following parameters values: L = 251, p0 = 0.8, f = 0.2,
pdrugc = 0.7, tap = 500, and two values for pdrugn: 10−4 (dark grey), and 10−2 (light
grey).
corresponding to successful treatment (cure) and unsuccessful treatment (non-
cure), respectively. In each figure, two values of pdrugn are considered. It can be
clearly seen that, for both values of pdrugn, the success of the treatment does
not change. It is also clear that the tumor size increases until tap (see figures
6a and 6b). However when pdrugc > p0, the reduction in tumor size starts, as
expected, after tap time steps.
When treatment is successful (pdrugc > p0), it was found that, for an upper
value of pdrugn (pdrugn = 10
−2; light grey), more normal cells are eliminated
compared with a lower value of pdrugn - pdrugn = 10
−4 as shown in Figure
6a (dark grey). Therefore, we may conclude that very small values of pdrugn
correspond to optimal therapy. However, in the case of unsuccessful treatment
(pdrugc < p0), when pdrugn is increased, both a decrease in the number of
normal cells and a slower rate of increase of cancer cells is found (see fig 6b).
A systematic analysis of the parameter space presented in the next section
will provide a more precise conclusion about the role of pdrugn parameter.
In order to analyze the effect of therapy on cancer cells, the time-spatial dis-
tribution of the simulated tumors was followed using the g2 package. Figure 7
shows the configuration of the lattice at different time steps from the beginning
of therapy until the tumor is eliminated.
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Fig. 7. The spatial distribution of states at consequent time steps (see the time step
bar) using the same parameters values of Figure 6a except L = 81. The final time
step is tfinal = 1400. Dark colors (light grey, grey, dark grey, and black) correspond,
respectively, to normal, cancer, necrotic cells, and empty sites.
4 RESULTS: PARAMETER SPACE
Analysis of the parameter space is important in order to confirm the robustness
of the model and to identify the most relevant parameters for the dynamics
of the model.
According to the relevance of some CA parameters to the features of the
phenomenon, this analysis of parameter space was divided into two parts:
the occurrence of necrosis (no treatment cases) and reaching a state of cure
(treatment cases).
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4.1 THE OCCURRENCE OF NECROSIS
In the first part, the parameters are again established as: pdrugn = pdrugc =
tap = 0 with the aim of evaluating the effect of necrosis, and the minimum
value of f is obtained for each pair of values (L; p0). The values of L are
presumed to range from 101 to 251, increasing the interval by ∆L = 25.
With respect to p0, the whole interval from 0.1 to 0.9 is taken into account,
increasing ∆pmitot(t) = 0.1. Figure 8 shows that a transition exists between
the nonnecrotic (lower) and necrotic (upper) regions of parameter space.
It was found that:
fmin = a(L)p0 + b(L) (4)
where the linear and the angular coefficients, b(L) and a(L) are different for
distinct values of the lattice size.
Fig. 8. a) Parameter space in the case of no treatment: fmin×p0×L; the following
parameters values are fixed: pdrugn = 0, pdrugc = 0; tfinal = 5000. b) the dependence
of the angular coefficient of fmin, a(L), with L.
The angular coefficient a(L) = a0L
γ where a0 = 1.12 and γ = 0.29 (see figure
8b).
Since the lattice size is an intrinsic parameter of the model, that transition
is such that the the maximal growth probability p0 is the control parameter,
while the necrotic parameter f is the order parameter.
4.2 REACHING THE CURE STATE
If the tumor is submitted to systemic treatment represented by a probability
pdrugc 6= 0 starting at tap 6= 0 that affects normal cells with a probability
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Fig. 9. Parameter subspace of treatment case: pmindrugc × p0 × tap; the following pa-
rameters values are fixed: L = 251, f = 0.6, pdrugn = 10−4; tfinal = 5000.
pdrugn < pdrugc, our aim is to establish the minimum value of pdrugc in order to
achieve a state of cure, i.e., no cancer cells.
The analysis is now more complex than the one performed in subsection 4.1 in
the sense that there are 4 important parameters that control the behavior of
the therapeutic effect: pdrugc, pdrugn, tap, and p0. The relevance of p0 is evident
in subsection 3.2. This analysis is divided into two parts.
In the first part, motivated by the behavior observed in figure 6a, the pa-
rameter is defined as pdrugn, assuming very small values (pdrugn = 10
−4) to
simulate optimal therapy. Lattice size is also established as L = 251 and the
necrotic parameter f = 0.6. Analogously to the method applied in subsection
4.1, the minimum value of pdrugc was obtained for each pair of values (p0; tap).
The range of values for p0 and tap are, respectively, [0.1; 0.9] and [0; tfinal].
Figure 9 shows the relevant role of p0 dividing the parameter subspace into
two regions: the lower is the non-cure state while the upper corresponds to
the state of cure. In this case p0 is again the control parameter but pdrugc is
the order parameter.
In the second part, a value of p0 = 0.8 remains fixed, while the pair varies
(pdrugn; tap), again in order to obtain the minimum value of pdrugc that would
be sufficient to effectively eliminate the tumor, now related to the effect of the
drug on the normal cells. The whole interval of pdrugn was taken into account
from very small values 10−4 until 0.9. It would be necessary to extend tfinal
in order to maintain the duration of application, since in this analysis the
parameter tap varied. Since this behavior is similar for any value of pdrugn, in
figure 10 the minimum value of pdrugc is shown to increase as a function of tap
in accordance with a Lorentzian function:
pmindrugc = A0 +
2A1
pi
A3
4(tap − A2)2 + A23
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Fig. 10. Parameter subspace of treatment case: pmindrugc×tap; the following parameters
values are fixed: L = 251, f = 0.6, p0 = 0.6; pdrugn = 10−4; δt = tfinal − tap = 500.
The Lorentzian fitting (grey color) parameters are A0 = 0.60, A1 = 186.61,
A2 = 4829.92, A3 = 776.29.
Fig. 11. Analysis of cure time in the treatment case: tcure×pmindrugc×tap; the following
parameters values are fixed: L = 251, f = 0.6, p0 = 0.6, pdrugn = 10−4, tfinal = 500.
This result means that the minimal rate of infusion of the drug to eliminate
the tumor has to be greater if the treatment begins later. It emphasizes how
important it is to initiate treatment as early as possible in order to reduce the
infusion rate of the drug.
Finally in the cases in which the tumor is eliminated (pdrugc > p0), for fixed
values of L, f , p0 and pdrugn, the cure time (tcure) is estimated in relation
to the initial time application tap, and pdrugc (see Figure 11). Note that tcure
is not a parameter but a consequence of the time evolution of the system.
Figure refFigure11 shows that tcure increases linearly with tap with an angular
coefficient equal to 1. Figure 11 also shows that, for a fixed tap, tcure decreases
with pdrugc. This result also shows how important it is to start treatment as
early as possible to reduce the amount of time required to reach the state of
cure.
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5 DISCUSSION AND CONCLUDING REMARKS
The model proposed in this study is capable of capturing the Gompertzian
behavior of avascular tumor growth. The competition between normal and
cancer cells and the dynamic character of the mitotic probability are the rel-
evant components of the success of this model.
The number of cancer cells simulates tumors in vitro due to the two-dimensional
character of the model, and their potential growth simulates a tumor in vivo
due to its three-dimensional nature. Figures 2 and 4 show that the model is
able to capture the dynamics of both in vivo and in vitro avascular tumor
growth. The simulated values for the most important Gompertzian parame-
ter β, which characterizes the Gompertzian shape, are compatible with the
parameter values of some tumors [6] [7].
The model is also able to capture necrotic and nonnecrotic tumors depending
on the values of the parameter f . It is well-known that necrosis, unlike apop-
tosis, is a typical phenomenon found in a group of cells that is simulated in
our model by the changing of the potential growth of the cells.
The time-spatial patterns reveal a tumor with a compact shape and irregular
boundaries, as occurs in some solid tumors [12], [30]. Evidence was also found
to confirm the three stages of avascular tumor growth [24]:
a) Stage I - when the tumor grows exponentially due to available resources
(nutrients and oxygen) - see first stage in Figure 5;
b) Stage II - when the stabilization of ∆pmitot starts but there are still
enough resources to ensure that necrosis does not occur - see second stage
in Figure 5b;
c) Stage III - when necrosis may occur depending on the value of the pa-
rameter f because the resources are insufficient to provide for tumor growth
- see third stage in Figure 5c in the case of necrosis.
The next stage, the angiogenic phase of the tumor [31], which has not yet
been dealt with in our model, corresponds to vascular growth. To be able to
evaluate this stage, the process of angiogenesis would have to be taken into
account [24].
In the case of no treatment (pdrugc = pdrugn = 0), the minimum value of f for
necrosis to occur is governed by the equation (4) that was obtained from the
investigation of the parameter space. This means that, for a simulated tissue
of dimension L, the occurrence of necrosis depends linearly on the maximum
value of mitotic probability of the specific tumor.
In relation to the case in which therapy was implemented, a continuous strat-
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egy of systemic therapy, i.e. chemotherapy, was selected. Although the schedule
of chemotherapy is usually periodic, in this case it was decided to simulate
this less realistic situation so that the effect of the parameters p0 and pdrugc
could be compared in a simple fashion. It was thus found that, with respect
to avascular tumor growth, when the values of the parameter pdrugn are very
small and when pdrugc is slightly greater than p0, the tumor is completely elim-
inated (see Figure 7). Since neovascularization has not yet been triggered, a
state of cure may be expected to occur with a periodic schedule.
The time-spatial patterns of the cases in which therapy was implemented (see
Figure 8) show that the drug acts from the borders of the simulated solid
tumor inwards, as would be expected in the case of solid tumors.
With respect to the effect of parameters on the state of cure, for fixed values
of lattice size L and necrotic parameter f , and for a range of values of tap
and pdrugn, the minimum value of pdrugc again coincides with p0 (see Figure
9). This reinforces the importance of the higher value of p0 in the response of
the tumor to therapy. It retains the memory of cancer cells with respect to
the onset of mitosis.
Finally, Figures 10 and 11 illustrate a very relevant finding from the phe-
nomenological point of view: the importance of initiating therapy as early as
possible in order to reach the state of cure. The cure time was found to be
proportional to tap that measures the instant when the infusion starts (see
Figure 11) and the minimum value of the therapeutic infusion to eliminate
the tumor increases nonlinearly as a function of the starting point of therapy.
Future studies should be carried out to generalize the model with the objec-
tive of including the angiogenic process and the periodic schedule of systemic
therapy. However, the most important perspective of this line of investigation
is to compare the model with the in vitro tumor growth of cells from specific
tissue samples and to compare parameter values. It would then be possible to
relate the Gompertzian fitting parameters with the parameters of the model.
Acknowledgements: The authors would like to thank Ramon El-Bacha´ for
his very useful discussions on the process of tumor growth and Nelson Alves
Jr. for his valuable collaboration at the beginning of this study and his help
in manipulating the time spatial patterns. This work is partially supported
by CNPq – Conselho Nacional de Desenvolvimento Cient´ıfico e Tecnolo´gico
(Brazilian Agency).
16
References
[1] The World Health Report 2006: Working Together for Health (World Health
Report).
[2] L. Preziosi (editor), Cancer Modelling and Simulation, Chapman & Hall/CRC,
London, 2003.
[3] E. Y. Rodin (editor-in-chief), A. Y. Yakovlev and S. H. Moolgavkar (guest
editors), Modeling and data analysis in cancer studies, Math. Comp. Mod. 33,
n. 12-13, 2001.
[4] T. E. Wheldon, Mathematical Models in Cancer Research, Adam Hilger, Bristol,
1988.
[5] A. K. Laird, Dynamics of tumour growth: comparison of growth rates and
extrapo lation of growth curves to one cell. Br. J. Cancer 19 (1965) 278-291.
[6] R. Demicheli, Growth of Testicular Neoplasm Lung Metastases: Tumor-Specific
Relation between two Gompertzian Parameters. Eur. J. Cancer 16 (1980), 1603-
1608
[7] G. F. Brunton and T. E. Wheldon, The Gompertz equation and the construction
of tumor growth curves. Cell Tissue Kinet. 13 (1980), 455-460.
[8] S. E. Clare, F. Nakhlis, and J. C. Panetta, Molecular biology of breast cancer
metastasis: The use of mathematical models to determine relapse and to predict
response to chemotherapy in breast cancer. Breast Cancer Res. 2 (2000),
430435.
[9] J. A. Spratt, D. von Fournier, J. S. Spratt, E. E. Weber, Decelarating Growth
and Human Breast Cancer. Cancer 71 (1993), 2013-2019.
[10] N. Bellomo and L. Preziosi, Modelling and Mathematical Problems Related
to Tumor Evolution and Its Interaction with the Immune System. Mathl. and
Comput. Modelling 32 (2000), 413-452.
[11] C. Guiot, P. G. Degiorgis, P. P. Delsanto, P. Gabriele, T. S. Deisboeck, Does
tumor growth follow a ”universal law”?. J. Theor. Biol. 225 (2003), 147-151.
[12] A. A. Patel, E. T. Gawlinskia, S. K. Lemieuxe, and R. A. Gatenbyb, A Cellular
Automaton Model of Early Tumor Growth and Invasion*: The Effects of Native
Tissue Vascularity and Increased Anaerobic Tumor Metabolism. J. theor. Biol.
213 (2001), 315-331.
[13] M. A. A. Castro, F. Klamt, V. A. Grieneisen, I. Grivicich, and J. C. F. Moreira,
umour cell phenotype Gompertzian growth pattern correlated with phenotypic
organization of colon carcinoma, malignant glioma and non-small cell lung
carcinoma cell lines. Cell Prolif. 36 (2003) 6573.
[14] S. Galam, and J. P. Radonski, Cancerous tumor: the high frequency of a rare
event, Phys. Rev. E 63 (2001) 051907.
17
[15] AN-S. Qi, X. Zheng, C-Y. Du, and B-S. An, A cellular automaton model of
cancerous growth, J. Theor. Biol. 161 (1993) 1-12.
[16] S. Dormann and A. Deutsch, Modeling of self-organized avascular tumor growth
with a hybrid cellular automaton. In Silico Biology 2 (2002), 0035.
[17] P. Gerlee and A.R.A. Anderson, An evolutionary hybrid cellular automaton
model of solid tumour growth, J. Theor. Biol. 246 (2007) 583603.
[18] K. Rygaard and M Spang-Thomsen, Comparative Gompertzian Analysis of
Alterations of Tumor Growth Patterns, Cancer Res. 54 (1994) 4385-4392.
[19] R. Martin and K. L. Teo, Optimal control of drug administration in cancer
chemotherapy, World Scientific, Singapore, 1994.
[20] G. W. Swan, Role of Optimal Control Theory in Cancer Chemotherapy, Math.
Biosci. 101 (1990), 237-284.
[21] J. M. Murray, Optimal Drug Regimens in Cancer Chemotherapy for Single
Drugs that Block Progression through the Cell Cycle, Math. Biosci. 123 (1994),
183-193 (1994).
[22] M. I. S. Costa, J. L. Boldrini and R. C. Bassanezi, Chemotherapeutic
Treatments Involving Drug Resistance and Level of Normal Cells as a Criterion
of Toxicity, Math. Biosci. 125 (1995), 211-228.
[23] A. S. Matveev and A. V. Savkin, Optimal chemotherapy regimens: influence of
tumors on normal cells and several toxicity constraints, IMA J. Math. Appl.
Med. Biol. 18 (2001), 25-40.
[24] J. A. Adam and S. A. Maggelakis, Diffusion regulated growth characteristics of
a spherical prevascular carcinoma, Bull. Math. Biol. 52 (1990) 549-582.
[25] S. Wolfram, Cellular Automata and Complexity. Addison-Wesley Publishing
Company, New York, 1994.
[26] B. Alberts, A. Johnson, J. Lewis, M. Raff, K, Roberts, and P. Walter Molecular
biology of the cell, Taylor and Francis Books, New York, 2002.
[27] S.C. Ferreira Junior, M.L. Martins, and M.J. Vilela, Morphology transitions
induced by chemotherapy in carcinomas in situ, Phys. Rev. E 67 (2003), 051914.
[28] Milanovic Lj., Wagner, H. , g2 - graphic library (C) 1999
(http://g2.sourceforge.net)
[29] A. R. Kansal, S. Torquato, E. A. Chiocca, and T. S. Deisboeck, Emergence of a
subpopulation in a computational model of tumor growth., J. Theor. Biol. 207
(2000), 431-441.
[30] S.C. Ferreira Junior, M.L. Martins, and M.J. Vilela, A growth model for primary
cancer. Physica A 261 (1998) 569-580.
[31] J. Folkman, Tumor Angiogenesis: Therapeutic implications. N. Engl. J. Med.
285 (1971) 11821186.
18
